Download PDF
J Neurol Surg B Skull Base 2018; 79(06): 533-537
DOI: 10.1055/s-0038-1635255
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Morbidity and Volumetric Progression in Juvenile Nasopharyngeal Angiofibroma in a Long-Term Follow-Up

Lorenz Epprecht   *
1   Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Switzerland
,
Marc Mosimann   *
1   Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Switzerland
,
Domenic Vital
1   Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Switzerland
,
David Holzmann
1   Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Switzerland
› Author Affiliations Funding Sources None.
Further Information

Publication History

11 September 2017

21 February 2018

Publication Date:
09 April 2018 (online)

    Permissions and Reprints

Abstract

Objective We compare the open and transnasal approaches for the excision of juvenile nasopharyngeal angiofibromas regarding the rate of morbidity, and residual tumor and its symptomatic recurrence over time. In addition, we present volumetric measurements of juvenile nasopharyngeal angiofibromas over time.

Methods All surgically treated patients of our institution were reviewed back to 1969 for type of surgery, residual tumor by magnetic resonance imaging (MRI)-based volumetry, recurrence, and morbidity. We performed a prospective clinical and radiological follow-up on reachable patients.

Results In total, 40 patients were retrievable from our records. We were able to follow up on 13 patients after a mean of 15.7 years since surgery (range: 1–47 years). Patients operated by the open approach had a higher rate of postoperative complications and thus a higher morbidity than endoscopic patients (4/4 vs 3/9; p = 0.007), although tumor sizes were equal among groups (p = 0.12). Persisting tumor was noted in 3/4 and 4/9 (p = 0.56) patients, respectively. The corresponding mean volumes of residual tumors were 16.2 ± 14.4 cm3 and 10.8 ± 6.6 cm3 (p = 0.27). No progression could be noted in endoscopically treated patients (p = 0.24, mean time between scans 2 years).

Conclusions Our analysis shows that the endoscopic approach results in less morbidity. The open approach does not guarantee freedom from persisting tumor tissue. Age seems to be a most important risk factor for the conversion of an asymptomatic persistence into a symptomatic recurrence.

Keywords

angiofibroma - follow-up - morbidity - endoscopic surgery - infratemporal approach

* Authors contributed equally.


 

  • References

  • 1 Boghani Z, Husain Q, Kanumuri VV. , et al. Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. Laryngoscope 2013; 123 (04) 859-869
    CrossrefPubMedGoogle Scholar
  • 2 Renkonen S, Hagström J, Vuola J. , et al. The changing surgical management of juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 2011; 268 (04) 599-607
    CrossrefPubMedGoogle Scholar
  • 3 Nicolai P, Villaret AB, Farina D. , et al. Endoscopic surgery for juvenile angiofibroma: a critical review of indications after 46 cases. Am J Rhinol Allergy 2010; 24 (02) e67-e72
    CrossrefPubMedGoogle Scholar
  • 4 Andrews JC, Fisch U, Valavanis A, Aeppli U, Makek MS. The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach. Laryngoscope 1989; 99 (04) 429-437
    CrossrefPubMedGoogle Scholar
  • 5 Zhang M, Garvis W, Linder T, Fisch U. Update on the infratemporal fossa approaches to nasopharyngeal angiofibroma. Laryngoscope 1998; 108 (11 Pt 1): 1717-1723
    CrossrefPubMedGoogle Scholar
  • 6 Baser B, Kothari S, Kinger A. Endoscopic approach to Fisch stage II to III-b juvenile nasopharyngeal angiofibroma. Indian J Otolaryngol Head Neck Surg 2011; 63 (01) 1-4
    PubMedGoogle Scholar
  • 7 Ardehali MM, Samimi Ardestani S-H, Yazdani N, Goodarzi H, Bastaninejad S. Endoscopic approach for excision of juvenile nasopharyngeal angiofibroma: complications and outcomes. Am J Otolaryngol 2010; 31 (05) 343-349
    CrossrefPubMedGoogle Scholar
  • 8 Khoueir N, Nicolas N, Rohayem Z, Haddad A, Abou Hamad W. Exclusive endoscopic resection of juvenile nasopharyngeal angiofibroma: a systematic review of the literature. Otolaryngol Head Neck Surg 2014; 150 (03) 350-358
    CrossrefPubMedGoogle Scholar
  • 9 Risley J, Mann K, Jones NS. The role of embolisation in ENT: an update. J Laryngol Otol 2012; 126 (03) 228-235
    CrossrefPubMedGoogle Scholar
  • 10 Huang Y, Liu Z, Wang J, Sun X, Yang L, Wang D. Surgical management of juvenile nasopharyngeal angiofibroma: analysis of 162 cases from 1995 to 2012. Laryngoscope 2014; 124 (08) 1942-1946
    CrossrefPubMedGoogle Scholar
  • 11 Godoy MDCL, Bezerra TFP, Pinna FdeR, Voegels RL. Complications in the endoscopic and endoscopic-assisted treatment of juvenile nasopharyngeal angiofibroma with intracranial extension. Rev Bras Otorrinolaringol (Engl Ed) 2014; 80 (02) 120-125
    PubMedGoogle Scholar
  • 12 Sun XC, Wang DH, Yu HP, Wang F, Wang W, Jiang JJ. Analysis of risk factors associated with recurrence of nasopharyngeal angiofibroma. J Otolaryngol Head Neck Surg 2010; 39 (01) 56-61
    PubMedGoogle Scholar
  • 13 Cloutier T, Pons Y, Blancal J-P. , et al. Juvenile nasopharyngeal angiofibroma: does the external approach still make sense?. Otolaryngol Head Neck Surg 2012; 147 (05) 958-963
    CrossrefPubMedGoogle Scholar
  • 14 Tyagi I, Syal R, Goyal A. Recurrent and residual juvenile angiofibromas. J Laryngol Otol 2006; 2007 (121) 460-467
    PubMedGoogle Scholar
  • 15 Weprin LS, Siemers PT. Spontaneous regression of juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 1991; 117 (07) 796-799
    CrossrefPubMedGoogle Scholar
  • 16 Liang J, Yi Z, Lianq P. The nature of juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 2000; 123 (04) 475-481
    CrossrefPubMedGoogle Scholar
  • 17 Llorente JL, López F, Suárez V, Costales M, Suárez C. Evolution in the treatment of juvenile nasopharyngeal angiofibroma [in Spanish]. Acta Otorrinolaringol Esp 2011; 62 (04) 279-286
    CrossrefPubMedGoogle Scholar
  • 18 Panda NK, Gupta G, Sharma S, Gupta A. Nasopharyngeal angiofibroma-changing trends in the management. Indian J Otolaryngol Head Neck Surg 2012; 64 (03) 233-239
    CrossrefPubMedGoogle Scholar